Brief: Xspray Pharma Comments On Dasynoc, Sprycel Uptake

Xspray Pharma publ AB

08/11/2023 15:41

Nov 8 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * DASYNOC UPTAKE INTO BLOOD REMAINS CONSISTENT WHEN TAKEN
WITH
OMEPRAZOLE
    * SPRYCEL® UPTAKE IS SIGNIFICANTLY MORE IMPAIRED THAN
PREVIOUSLY
UNDERSTOOD
    * DASYNOC'S UPTAKE INTO BLOOD WAS NOT AFFECTED 10 HOURS
AFTER
TAKING OMEPRAZOLE
    * UPTAKE OF SPRYCEL WAS SIGNIFICANTLY REDUCED 10 HOURS AFTER
TAKING OMEPRAZOLE

Source text for Eikon:  ID:nBw1sw048a 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))